Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation
Antibody concentrations to vaccine-preventable diseases decline following BMT and an optimal schedule for vaccination after transplant has not been established. We examined antibody responses to tetanus toxoid (TT) and Haemophilus influenzae type b-conjugate (HIB) vaccines of BMT patients immunized...
Gespeichert in:
| Veröffentlicht in: | Bone marrow transplantation (Basingstoke) 1998-10, Vol.22 (8), p.735-741 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 741 |
|---|---|
| container_issue | 8 |
| container_start_page | 735 |
| container_title | Bone marrow transplantation (Basingstoke) |
| container_volume | 22 |
| creator | VANCE, E GEORGE, S GUINAN, E. C WHEELER, C ANTIN, J. H AMBROSINO, D. M MOLRINE, D. C |
| description | Antibody concentrations to vaccine-preventable diseases decline following BMT and an optimal schedule for vaccination after transplant has not been established. We examined antibody responses to tetanus toxoid (TT) and Haemophilus influenzae type b-conjugate (HIB) vaccines of BMT patients immunized at 6, 12 and 24 months (6 month group, n = 21) and compared them to those previously reported for patients immunized at 3, 6, 12 and 24 months (3 month group, n = 74) or at 12 and 24 months (12 month group, n = 17) following transplantation. Geometric mean total anti-HIB and IgG anti-TT concentrations were significantly higher after the 12 month dose in the 3 and 6 month immunization groups compared to the group who received their first dose at 12 months. Although HIB antibody concentrations were higher in the 3 month and 6 month groups 12 to 24 months after BMT, the proportion of patients with protective levels was not significantly different from the proportion protected in the 12 month group. Following the 24 month immunizations, geometric mean antibody concentrations to HIB and TT were similar for all three immunization groups. The proportion of patients in each group with protective levels of HIB antibody after the 24 month dose was > or = 80%. A two dose schedule of HIB and TT vaccines at 12 and 24 months after BMT should afford protection. |
| doi_str_mv | 10.1038/sj.bmt.1701424 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70056661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70056661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-81e7c8b95bca7b9c7ba4fa5c37049286b76101738577be8c013d002b88b8eca3</originalsourceid><addsrcrecordid>eNqFkb1v1TAUxS0EKo_CyoZkCcSWhx0ntjOiJ9oiVWLpHtnOTevIsYM_6Me_wj-LaZ86sDB5OL97ru85CL2nZE8Jk1_Sstdr3lNBaNd2L9COdoI3PeP9S7QjLZcNY3x4jd6ktJDKdKQ_QSeDbMXAhx36fQjrpqJNweMw47W4bDcH2K5r8fZBZVuFZG5gKg4SnkPEFwrWsN1YVxK2fnYF_IMCnO83wLoxwS_lWmXAyk84Q1a-cjncBTvhX8oY6x99nAu31l9jHTzgVcUYbnGOyqfNKZ8f975Fr2blErw7vqfo6uzb1eGiufxx_v3w9bIxHZW5kRSEkXrotVFCD0Zo1c2qN0yQbmgl14JTQgWTvRAapCGUTYS0WkotwSh2ij4_2W4x_CyQ8rjaZMDVf0AoaRSE9Jxz-l-QCjrUhPsKfvwHXEKJvt4wtrxrac8GISu1f6JMDClFmMct2prE_UjJ-LfbMS1j7XY8dlsHPhxti15hesaPZVb901FXySg31zSNTc9Y29EKCfYHSFqxUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2642153978</pqid></control><display><type>article</type><title>Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Nature Journals Online</source><creator>VANCE, E ; GEORGE, S ; GUINAN, E. C ; WHEELER, C ; ANTIN, J. H ; AMBROSINO, D. M ; MOLRINE, D. C</creator><creatorcontrib>VANCE, E ; GEORGE, S ; GUINAN, E. C ; WHEELER, C ; ANTIN, J. H ; AMBROSINO, D. M ; MOLRINE, D. C</creatorcontrib><description>Antibody concentrations to vaccine-preventable diseases decline following BMT and an optimal schedule for vaccination after transplant has not been established. We examined antibody responses to tetanus toxoid (TT) and Haemophilus influenzae type b-conjugate (HIB) vaccines of BMT patients immunized at 6, 12 and 24 months (6 month group, n = 21) and compared them to those previously reported for patients immunized at 3, 6, 12 and 24 months (3 month group, n = 74) or at 12 and 24 months (12 month group, n = 17) following transplantation. Geometric mean total anti-HIB and IgG anti-TT concentrations were significantly higher after the 12 month dose in the 3 and 6 month immunization groups compared to the group who received their first dose at 12 months. Although HIB antibody concentrations were higher in the 3 month and 6 month groups 12 to 24 months after BMT, the proportion of patients with protective levels was not significantly different from the proportion protected in the 12 month group. Following the 24 month immunizations, geometric mean antibody concentrations to HIB and TT were similar for all three immunization groups. The proportion of patients in each group with protective levels of HIB antibody after the 24 month dose was > or = 80%. A two dose schedule of HIB and TT vaccines at 12 and 24 months after BMT should afford protection.</description><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/sj.bmt.1701424</identifier><identifier>PMID: 9827969</identifier><identifier>CODEN: BMTRE9</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject><![CDATA[Adolescent ; Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Antibodies ; Biological and medical sciences ; Bone marrow ; Bone marrow transplantation ; Bone Marrow Transplantation - adverse effects ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Child ; Child, Preschool ; Conjugates ; Female ; Haemophilus Infections - etiology ; Haemophilus Infections - immunology ; Haemophilus Infections - prevention & control ; Haemophilus influenzae ; Haemophilus influenzae - immunology ; Haemophilus Vaccines - administration & dosage ; Haemophilus Vaccines - immunology ; Humans ; Immunization ; Immunization Schedule ; Immunoglobulin G ; Immunosuppression - adverse effects ; Male ; Medical sciences ; Middle Aged ; Schedules ; Stem cell transplantation ; Tetanus ; Tetanus - etiology ; Tetanus - prevention & control ; Tetanus Toxoid - administration & dosage ; Tetanus Toxoid - immunology ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Transplantation ; Transplantation, Homologous ; Transplants & implants ; Vaccines ; Vaccines, Conjugate - administration & dosage ; Vaccines, Conjugate - immunology]]></subject><ispartof>Bone marrow transplantation (Basingstoke), 1998-10, Vol.22 (8), p.735-741</ispartof><rights>1998 INIST-CNRS</rights><rights>Macmillan Publishers Limited 1998.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-81e7c8b95bca7b9c7ba4fa5c37049286b76101738577be8c013d002b88b8eca3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2416937$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9827969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VANCE, E</creatorcontrib><creatorcontrib>GEORGE, S</creatorcontrib><creatorcontrib>GUINAN, E. C</creatorcontrib><creatorcontrib>WHEELER, C</creatorcontrib><creatorcontrib>ANTIN, J. H</creatorcontrib><creatorcontrib>AMBROSINO, D. M</creatorcontrib><creatorcontrib>MOLRINE, D. C</creatorcontrib><title>Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><description>Antibody concentrations to vaccine-preventable diseases decline following BMT and an optimal schedule for vaccination after transplant has not been established. We examined antibody responses to tetanus toxoid (TT) and Haemophilus influenzae type b-conjugate (HIB) vaccines of BMT patients immunized at 6, 12 and 24 months (6 month group, n = 21) and compared them to those previously reported for patients immunized at 3, 6, 12 and 24 months (3 month group, n = 74) or at 12 and 24 months (12 month group, n = 17) following transplantation. Geometric mean total anti-HIB and IgG anti-TT concentrations were significantly higher after the 12 month dose in the 3 and 6 month immunization groups compared to the group who received their first dose at 12 months. Although HIB antibody concentrations were higher in the 3 month and 6 month groups 12 to 24 months after BMT, the proportion of patients with protective levels was not significantly different from the proportion protected in the 12 month group. Following the 24 month immunizations, geometric mean antibody concentrations to HIB and TT were similar for all three immunization groups. The proportion of patients in each group with protective levels of HIB antibody after the 24 month dose was > or = 80%. A two dose schedule of HIB and TT vaccines at 12 and 24 months after BMT should afford protection.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Antibodies</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Bone marrow transplantation</subject><subject>Bone Marrow Transplantation - adverse effects</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Conjugates</subject><subject>Female</subject><subject>Haemophilus Infections - etiology</subject><subject>Haemophilus Infections - immunology</subject><subject>Haemophilus Infections - prevention & control</subject><subject>Haemophilus influenzae</subject><subject>Haemophilus influenzae - immunology</subject><subject>Haemophilus Vaccines - administration & dosage</subject><subject>Haemophilus Vaccines - immunology</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Schedule</subject><subject>Immunoglobulin G</subject><subject>Immunosuppression - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Schedules</subject><subject>Stem cell transplantation</subject><subject>Tetanus</subject><subject>Tetanus - etiology</subject><subject>Tetanus - prevention & control</subject><subject>Tetanus Toxoid - administration & dosage</subject><subject>Tetanus Toxoid - immunology</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Transplantation</subject><subject>Transplantation, Homologous</subject><subject>Transplants & implants</subject><subject>Vaccines</subject><subject>Vaccines, Conjugate - administration & dosage</subject><subject>Vaccines, Conjugate - immunology</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1v1TAUxS0EKo_CyoZkCcSWhx0ntjOiJ9oiVWLpHtnOTevIsYM_6Me_wj-LaZ86sDB5OL97ru85CL2nZE8Jk1_Sstdr3lNBaNd2L9COdoI3PeP9S7QjLZcNY3x4jd6ktJDKdKQ_QSeDbMXAhx36fQjrpqJNweMw47W4bDcH2K5r8fZBZVuFZG5gKg4SnkPEFwrWsN1YVxK2fnYF_IMCnO83wLoxwS_lWmXAyk84Q1a-cjncBTvhX8oY6x99nAu31l9jHTzgVcUYbnGOyqfNKZ8f975Fr2blErw7vqfo6uzb1eGiufxx_v3w9bIxHZW5kRSEkXrotVFCD0Zo1c2qN0yQbmgl14JTQgWTvRAapCGUTYS0WkotwSh2ij4_2W4x_CyQ8rjaZMDVf0AoaRSE9Jxz-l-QCjrUhPsKfvwHXEKJvt4wtrxrac8GISu1f6JMDClFmMct2prE_UjJ-LfbMS1j7XY8dlsHPhxti15hesaPZVb901FXySg31zSNTc9Y29EKCfYHSFqxUw</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>VANCE, E</creator><creator>GEORGE, S</creator><creator>GUINAN, E. C</creator><creator>WHEELER, C</creator><creator>ANTIN, J. H</creator><creator>AMBROSINO, D. M</creator><creator>MOLRINE, D. C</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19981001</creationdate><title>Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation</title><author>VANCE, E ; GEORGE, S ; GUINAN, E. C ; WHEELER, C ; ANTIN, J. H ; AMBROSINO, D. M ; MOLRINE, D. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-81e7c8b95bca7b9c7ba4fa5c37049286b76101738577be8c013d002b88b8eca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Antibodies</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Bone marrow transplantation</topic><topic>Bone Marrow Transplantation - adverse effects</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Conjugates</topic><topic>Female</topic><topic>Haemophilus Infections - etiology</topic><topic>Haemophilus Infections - immunology</topic><topic>Haemophilus Infections - prevention & control</topic><topic>Haemophilus influenzae</topic><topic>Haemophilus influenzae - immunology</topic><topic>Haemophilus Vaccines - administration & dosage</topic><topic>Haemophilus Vaccines - immunology</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Schedule</topic><topic>Immunoglobulin G</topic><topic>Immunosuppression - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Schedules</topic><topic>Stem cell transplantation</topic><topic>Tetanus</topic><topic>Tetanus - etiology</topic><topic>Tetanus - prevention & control</topic><topic>Tetanus Toxoid - administration & dosage</topic><topic>Tetanus Toxoid - immunology</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Transplantation</topic><topic>Transplantation, Homologous</topic><topic>Transplants & implants</topic><topic>Vaccines</topic><topic>Vaccines, Conjugate - administration & dosage</topic><topic>Vaccines, Conjugate - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VANCE, E</creatorcontrib><creatorcontrib>GEORGE, S</creatorcontrib><creatorcontrib>GUINAN, E. C</creatorcontrib><creatorcontrib>WHEELER, C</creatorcontrib><creatorcontrib>ANTIN, J. H</creatorcontrib><creatorcontrib>AMBROSINO, D. M</creatorcontrib><creatorcontrib>MOLRINE, D. C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VANCE, E</au><au>GEORGE, S</au><au>GUINAN, E. C</au><au>WHEELER, C</au><au>ANTIN, J. H</au><au>AMBROSINO, D. M</au><au>MOLRINE, D. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><addtitle>Bone Marrow Transplant</addtitle><date>1998-10-01</date><risdate>1998</risdate><volume>22</volume><issue>8</issue><spage>735</spage><epage>741</epage><pages>735-741</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><coden>BMTRE9</coden><abstract>Antibody concentrations to vaccine-preventable diseases decline following BMT and an optimal schedule for vaccination after transplant has not been established. We examined antibody responses to tetanus toxoid (TT) and Haemophilus influenzae type b-conjugate (HIB) vaccines of BMT patients immunized at 6, 12 and 24 months (6 month group, n = 21) and compared them to those previously reported for patients immunized at 3, 6, 12 and 24 months (3 month group, n = 74) or at 12 and 24 months (12 month group, n = 17) following transplantation. Geometric mean total anti-HIB and IgG anti-TT concentrations were significantly higher after the 12 month dose in the 3 and 6 month immunization groups compared to the group who received their first dose at 12 months. Although HIB antibody concentrations were higher in the 3 month and 6 month groups 12 to 24 months after BMT, the proportion of patients with protective levels was not significantly different from the proportion protected in the 12 month group. Following the 24 month immunizations, geometric mean antibody concentrations to HIB and TT were similar for all three immunization groups. The proportion of patients in each group with protective levels of HIB antibody after the 24 month dose was > or = 80%. A two dose schedule of HIB and TT vaccines at 12 and 24 months after BMT should afford protection.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>9827969</pmid><doi>10.1038/sj.bmt.1701424</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0268-3369 |
| ispartof | Bone marrow transplantation (Basingstoke), 1998-10, Vol.22 (8), p.735-741 |
| issn | 0268-3369 1476-5365 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70056661 |
| source | MEDLINE; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Nature Journals Online |
| subjects | Adolescent Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antibodies Biological and medical sciences Bone marrow Bone marrow transplantation Bone Marrow Transplantation - adverse effects Bone marrow, stem cells transplantation. Graft versus host reaction Child Child, Preschool Conjugates Female Haemophilus Infections - etiology Haemophilus Infections - immunology Haemophilus Infections - prevention & control Haemophilus influenzae Haemophilus influenzae - immunology Haemophilus Vaccines - administration & dosage Haemophilus Vaccines - immunology Humans Immunization Immunization Schedule Immunoglobulin G Immunosuppression - adverse effects Male Medical sciences Middle Aged Schedules Stem cell transplantation Tetanus Tetanus - etiology Tetanus - prevention & control Tetanus Toxoid - administration & dosage Tetanus Toxoid - immunology Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Homologous Transplants & implants Vaccines Vaccines, Conjugate - administration & dosage Vaccines, Conjugate - immunology |
| title | Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A33%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20multiple%20immunization%20schedules%20for%20Haemophilus%20influenzae%20type%20b-conjugate%20and%20tetanus%20toxoid%20vaccines%20following%20bone%20marrow%20transplantation&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=VANCE,%20E&rft.date=1998-10-01&rft.volume=22&rft.issue=8&rft.spage=735&rft.epage=741&rft.pages=735-741&rft.issn=0268-3369&rft.eissn=1476-5365&rft.coden=BMTRE9&rft_id=info:doi/10.1038/sj.bmt.1701424&rft_dat=%3Cproquest_cross%3E70056661%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2642153978&rft_id=info:pmid/9827969&rfr_iscdi=true |